Cancer therapy involves the use of drugs, radiation therapy, immunotherapy, targeted therapy and other techniques to treat cancer and help manage its symptoms. The rising burden of various types of cancer such as lung cancer, breast cancer, colorectal cancer and prostate cancer has boosted the demand for effective cancer therapies globally.

Cancer Therapy Market Size aid in shrinking or destroying cancerous tumors or cells through a variety of mechanisms. Some therapies may be used alone while some may be combined to achieve optimum results. With advancements in the field of oncology, targeted therapies that act on specific molecular pathways have emerged as an important treatment approach.

The Global cancer therapy market is estimated to be valued at US$ 231671.29 Bn in 2024 and is expected to exhibit a CAGR of 7.6% over the forecast period 2024 To 2031.


Key Takeaways

Key players operating in the cancer therapy are GE Healthcare, Siemens Healthcare GmbH, Seno Medical, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Hologic, Inc., Aurora Imaging Technologies, Inc., Canon Inc., Dilon Technologies, Inc., Leica Biosystems Nussloch GmbH (Danaher), Carestream Health, Avante Health Solutions, Hitachi, Ltd, PLANMED OY, and Barco. These players are focusing on developing innovative cancer therapies and technologies to improve treatment outcomes.

Get More Insights On, Cancer Therapy Market